跳至主要内容
临床试验/JPRN-jRCTs031220020
JPRN-jRCTs031220020招募中2 期

Effective prevention of atopic dermatitis by ingesting kestose compared to maltose in high-risk neonatesA sing le center, randomized, blinded, parallel, 2 group, phase II trial

Saito Mayako0 个研究点目标入组 100 人开始时间: 2022年4月13日最近更新:
适应症

试验速览

阶段
2 期
状态
招募中
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 < 1weeks old(—)
性别
All

入选标准

  • 1) At the time of obtaining the consent,the newborn was less than 6 days old
  • 2) A newborn with at least one parent of sibling who has had atopic dermatitis(high-risk newborn)
  • 3) Newborn infants whose parents have given written informed consent after receiving the explanation

排除标准

  • 1) Newborn infants who has already has atopic dermatitis
  • 2) Newborn infants using topical drug s such as steroids (excluding the topical and anal areas )
  • 3) Newborn infants with skin lesions such as abnormal keratinization and bullous disease
  • 4) Newborn born less than 37 weeks in g estation
  • 5) Newborn born by cesarean section
  • 6) Multiple fetuses
  • 7) Newborn with serious complications
  • 8) If they plan to move during the study period and may not be able to visit the research facility
  • 9) If the applicant cannot understand Japanese
  • 10) In addition, if the investig ator judg es it inappropriate

研究者

发起方
Saito Mayako

相似试验

Kestose Intake for prevention of atopic dermatitis... | 临床试验